BPC-157 10mg + TB-500 10mg x 10 Vials. BPC-157 is a synthetic pentadecapeptide: its peptide chain contains fifteen amino-acid residues. Its defined sequence makes it suitable for sequence-based identification and comparison with a qualified reference material. BPC-157 is discussed in experimental peptide literature; the identity of the molecule and the composition of a supplied research sample remain separate questions. TB-500 is a catalogue designation used in peptide research. Its relationship to thymosin beta-4 terminology requires particular care: the name alone is not a universally sufficient sequence specification. Before selecting a molecular reference, establish whether the supplied material is a defined fragment, a modified peptide or a full-length thymosin-related preparation. Pack: 10 vials. 10mg BPC-157 plus 10mg TB-500 per vial (20mg combined); 100mg plus 100mg across 10 vials (200mg combined). Intended exclusively for controlled in vitro laboratory research; not for human or veterinary use.